PANACEA BIOTEC
Back to Balance Sheet
|
PANACEA BIOTEC Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹367 Cr | ₹369 Cr | ₹656 Cr | ₹368 Cr | ₹407 Cr |
What is the latest Contingent Liabilities ratio of PANACEA BIOTEC ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹367 Cr |
| Mar2024 | ₹369 Cr |
| Mar2023 | ₹656 Cr |
| Mar2022 | ₹368 Cr |
| Mar2021 | ₹407 Cr |
How is Contingent Liabilities of PANACEA BIOTEC Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹367 Cr | -0.62 | |
| Mar2024 | ₹369 Cr | -43.67 | |
| Mar2023 | ₹656 Cr | 78.11 | |
| Mar2022 | ₹368 Cr | -9.54 | |
| Mar2021 | ₹407 Cr | - | |
Compare Contingent Liabilities of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹2,306.4 Cr | 5% | 3.7% | -9.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,626.0 Cr | -1% | -4.9% | -7.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,758.0 Cr | -1.6% | -0.4% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,021.0 Cr | 0.2% | 2.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹122,046.0 Cr | 1% | -0.9% | -1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,086.0 Cr | 0.4% | 0.9% | -8.9% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | 5% |
3.7% |
-9.6% |
| SENSEX | -0.4% |
-0.6% |
8.6% |
You may also like the below Video Courses